Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tadalafil 20mg tablets
0704050R0AAABAB
|
Tadalafil | Tadalafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 109,187 |
|
Tadalafil 5mg tablets
0704050R0AAADAD
|
Tadalafil | Tadalafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 64,528 |
|
Tadalafil 10mg tablets
0704050R0AAAAAA
|
Tadalafil | Tadalafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 61,492 |
|
Cialis 20mg tablets
0704050R0BBABAB
|
Cialis | Tadalafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 6,739 |
|
Tadalafil 2.5mg tablets
0704050R0AAACAC
|
Tadalafil | Tadalafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 4,525 |
|
Cialis 5mg tablets
0704050R0BBADAD
|
Cialis | Tadalafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 3,682 |
|
Cialis 10mg tablets
0704050R0BBAAAA
|
Cialis | Tadalafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1,433 |
|
Cialis 2.5mg tablets
0704050R0BBACAC
|
Cialis | Tadalafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 296 |
|
Avarante 10mg tablets
0704050R0BFAAAA
|
Avarante | Tadalafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | 1 |
|
Cialis Together 10mg tablets
0704050R0BEAAAA
|
Cialis Together | Tadalafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Stamiz 10mg tablets
0704050R0BGAAAA
|
Stamiz | Tadalafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Talmanco 20mg tablets
0704050R0BDAAAB
|
Talmanco | Tadalafil | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.